July 03, 2020
Nadim Yared, CEO of CVRx This week, CVRX reported positive six-month trial results for its Barostim Neo, an FDA-approved treatment for heart failure. The...
00:47:21
May 06, 2023
Last call for DeviceTalks Boston! In this episode we'll preview our upcoming conference by talking with Paul Grand, CEO of Medtech Innovator, Rebecca Whitney,...
01:17:24
April 12, 2024
In this episode of DeviceTalks Weekly, Greg Roche, CEO of Distalmotion, explains why smaller profile surgical robotic systems like Dexter have a shot at...
00:40:44